vCCI, or viral CC chemokine inhibitor, is a unique protein expressed by certain poxviruses that have evolved to modulate the host's immune response to their advantage. It operates by mimicking the normal function of cellular CC chemokine receptors, binding to CC chemokines with high affinity and thereby neutralizing their role in immune signaling. The vCCI protein acts as a decoy receptor, effectively sequestering CC chemokines and preventing them from guiding immune cells to the site of infection. This subversion of the host's immune system allows the virus to evade immune detection and establish an infection more effectively. The expression of vCCI is intricately linked to the viral life cycle and is tightly regulated by the virus's genetic machinery, which is in turn influenced by the intracellular environment of the host cell.
Investigating the chemicals capable of inducing the expression of vCCI revolves around understanding the environmental and cellular conditions that favor poxvirus replication, as vCCI expression is inherently tied to viral proliferation. Certain chemicals can potentially create an intracellular milieu that indirectly upregulates the production of vCCI by promoting conditions that are conducive to viral activity. For instance, molecules that induce cellular stress responses may inadvertently facilitate viral replication, thereby increasing the expression of viral proteins such as vCCI. Alternatively, compounds that interact with cellular regulatory pathways, like those involved in gene transcription and protein synthesis, might also lead to a rise in vCCI levels if they result in an environment that supports poxvirus replication. It is within these complex biological interactions that the potential for chemical induction of vCCI lies, opening the door to a deeper understanding of viral host interactions and the life cycle of poxviruses.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin may activate latent viral infections, potentially leading to the upregulation of vCCI during the course of viral replication. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 could stimulate latent viral reservoirs, which may result in the increased transcription of viral proteins, including vCCI. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could enhance the transcriptional activity of viral genes by altering chromatin structure, possibly leading to an upsurge in vCCI expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical could induce demethylation of viral DNA, potentially resulting in the transcriptional activation of vCCI in infected cells. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram may trigger the expression of latent viruses, which in turn could lead to an increase in vCCI production during viral replication. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may facilitate the transcription of latent viral genes by inhibiting histone deacetylases, potentially leading to an elevation in vCCI levels. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic Acid could stimulate a cellular environment that supports poxvirus replication, possibly resulting in the enhanced expression of vCCI. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin may induce a stress response that leads to the unfolded protein response, which could inadvertently upregulate vCCI expression during viral replication. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA could increase the activity of protein kinase C, potentially creating conditions that favor the replication of poxviruses and subsequent upregulation of vCCI. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A could stimulate immune cell proliferation, potentially leading to a heightened state of immune activation that could inadvertently stimulate poxvirus replication and vCCI expression. | ||||||